findmyKOL
Clinical trialNCT00003385CompletedPhase 1Interventional

Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer

SponsorGynecologic Oncology GroupEnrollment48Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Peter G. Rose, MD

    MetroHealth Cancer Care Center at MetroHealth Medical Center

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Norway
  • Norwegian Radium Hospital

    Oslo, Norway

United States
  • Mbccop - Hawaii

    Honolulu, Hawaii, United States

  • Holden Comprehensive Cancer Center

    Iowa City, Iowa, United States

  • Warren Grant Magnuson Clinical Center - Nci Clinical Studies Support

    Bethesda, Maryland, United States

  • Cleveland Clinic Taussig Cancer Center

    Cleveland, Ohio, United States

  • Ireland Cancer Center

    Cleveland, Ohio, United States

  • University of Texas Medical Branch

    Galveston, Texas, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 1999
Primary completion
31 Jan 2007
Completion
Last update posted
27 May 2013
Registered enrollment
48
Registry id
NCT00003385

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.